ICBEB 2024

2024 8th International Conference on Biomedical Engineering and Bioinformatics (ICBEB 2024)

Milan (Italy), 13-15 September 2024


Key deadlines
Conference starts:
2024-09-13
Paper Submission for Revision by:
2024-07-10
Website

Visit the conference website

Conference Description

2024 8th International Conference on Biomedical Engineering and Bioinformatics (ICBEB 2024) will be held during September 13-15, 2024 in Milan, Italy. It is organized by Biology and Bioinformatics Society (BBS) under Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES). ICBEB is an annually-held international conference devoted specifically to facilitate synergies in research and development in the areas of Biomedical Engineering and Bioinformatics. It provides the communication platform for those who are leading experts and scholars in Biomedical Engineering and Bioinformatics from around the world.

Conference Website: www.icbeb.net

Publication and Index:
International Conference Proceedings, which will be indexed by Ei Compendex and Scopus, and submitted to be reviewed by Thomson Reuters Conference Proceedings Citation Index (ISI Web of Science)
Or
International Journal of Pharma Medicine and Biological Sciences (IJPMBS, ISSN: 2278-5221), which will be indexed by Embase (Under elsevier), CNKI, ProQuest, Google Scholar, etc.

Conference Venue:
NH Milano Machiavelli
Addr: Via Lazzaretto,5,20124 Milano ltalia
Tel. +39 02 631141
Email: nhmachiavelli@nh-hotels.com
https://www.nh-hotels.com/it/hotel/nh-milano-machiavelli

Submission and Contact Methods:
Submission System: https://confsys.iconf.org/submission/icbeb2024
E-mail: icbeb@cbees.net
Tel: +852-3500-0799/+86-28-86528465
WeChat: CBEES-BBS
Conference Secretary: Ms. Stephanie Chen

ICBEB 2024 can provide a platform for academic communication in Biomedical Engineering and Bioinformatics and related areas. For more conference information, please visit the conference website: www.icbeb.net

Comments

No comments yet!

You must register or sign in to post a comment.